Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02948842 · ClinicalTrials.gov registry record · Phase 2
Clostridium Histolyticum Collagenase Injection for Urethral Disease
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02948842 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 5 participants.
The verdict
NCT02948842, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of clostridium histolyticum collagenase (XIAFLEX®) in treating urethral strictures.
Interventions
- OTHER Saline
- DRUG Clostridium Histolyticum Collagenase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-05-22 |
| Est. Completion | 2023-04-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02948842
The ClinicalTrials.gov registry entry for NCT02948842 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02948842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02948842 about?
NCT02948842 is a clinical study titled "Clostridium Histolyticum Collagenase Injection for Urethral Disease". The purpose of this study is to assess the efficacy of clostridium histolyticum collagenase (XIAFLEX®) in treating urethral strictures.
What is the current status of trial NCT02948842?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2020-05-22. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT02948842?
The interventions under investigation include: Saline (OTHER), Clostridium Histolyticum Collagenase (DRUG).
Who is sponsoring clinical trial NCT02948842?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.